Pharmaceutical formulations for minimizing drug-drug interactions

Details for Australian Patent Application No. 2006259594 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Gupta, Pramod; Rabinow, Barret E.; Cook, Chyung

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006259594

PCT Pub. Number WO2006/138202

Priority 11/423,491 12.06.06 US; 60/690,322 14.06.05 US

Filing date 12 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5517 (2006.01)

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/138202 Priority application(s): WO2006/138202

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259598-Pilot and data transmission in a MIMO system applying subband multiplexing

2006259593-Hair conditioning composition comprising silicone polymers containing quaternary groups